How Falling Fertility Threatens the Global Economy

Episode Summary

Executive Summary: The episode centers on the global decline in fertility rates and, through attorney-author Elizabeth Katkin’s personal story, shows how infertility is both a deeply personal struggle and a structural economic problem. It examines how U.S. fertility care is hindered by high costs, uneven insurance coverage, and fragmented surrogacy laws, while noting that scientific progress offers optimism even as policy solutions lag.

Main Topics: Global fertility decline and economic consequences (Priority: 5/5): The introduction frames falling birth rates as a major driver of slower population and workforce growth, with implications for housing, schools, labor supply, and long-term economic expansion. Elizabeth Katkin’s personal infertility journey (Priority: 5/5): Katkin recounts a nine-year path to have two children, including miscarriages, IVF cycles, and treatment in multiple countries, which motivates her book and broader research. U.S. fertility care costs and insurance gaps (Priority: 5/5): The conversation emphasizes that infertility treatment in the U.S. is often prohibitively expensive and inconsistently covered, leaving many patients to pay out of pocket. Surrogacy, donor regulation, and legal fragmentation (Priority: 4/5): The episode highlights the complexity of surrogacy and donor arrangements across states and countries, arguing that inconsistent laws create confusion, cost, and inequity. Medical tourism and cross-border treatment (Priority: 4/5): Examples from Spain and other countries show that some patients seek cheaper or more accessible fertility care abroad, underscoring U.S. system failures. Scientific optimism vs. policy pessimism (Priority: 4/5): Katkin is hopeful about advances in egg quality and embryo research, but skeptical that U.S. healthcare and political systems will quickly make fertility care broadly accessible.

Key Arguments: Fertility is not just a private issue; it is an economic one because population growth supports labor force growth and demand for goods and services. Infertility is increasingly common and less taboo to discuss, but the scale of the problem is also real and widespread. U.S. fertility care is unusually expensive and underinsured compared with many developed countries, making access heavily dependent on wealth. Insurance coverage often shapes treatment choices in ways that may reduce the chance of success, rather than simply enabling care. Fragmented state-by-state surrogacy laws force families to navigate a confusing and costly legal landscape. People with fewer financial resources are more likely to hit a dead end, while some patients can solve access problems by traveling abroad. Scientific progress in fertility research is advancing quickly, but policy and affordability have not kept pace.

Data Points: Average number of children per woman globally: about 2.5 today - Compared with 5 children 50 years ago, illustrating the fertility decline. Women in the U.S. confronting infertility: approximately 1 in 6 couples - Katkin cites this as evidence that infertility is widespread. Women seeking fertility help annually: about 7 million women a year - Estimate cited during discussion of infertility prevalence. Insurance coverage for fertility services: 15 states require some form of coverage - Shows how limited mandated fertility insurance is in the United States. States with restrictive coverage: 4 states require insurance only for married couples - Illustrates uneven and limited access to treatment. States with meaningful fertility coverage: about half a dozen - Katkin says only a small number of states have enough coverage to really help patients have a baby. Share of fertility costs paid out of pocket in the U.S.: 85% - Used to emphasize the financial burden on patients. Katkin’s infertility journey: 9 years - The length of time it took her to have two children. Pregnancy losses and treatment cycles: 7 miscarriages and 10 IVF cycles - Part of Katkin’s personal story of infertility and treatment. Countries where she saw doctors: 6 countries - Reflects the international scope of her treatment journey. Cost of an egg-donor IVF cycle in the U.S.: about $50,000 - One couple interviewed in the book considered this price before going abroad. All-in cost of treatment in Spain: 10,000 euros - Included IVF, medications, and travel for the couple profiled in the book.

Pivotal Quotes: "There are two kinds of people in the world: people who think about climate change and people who are doing something about it." — Promo narrator: Opening line from the pre-roll for the Zero podcast, contrasting concern with action. "In the United States, of course, we have no national health service, and as far as insurance coverage goes, only 15 states require any form of insurance." — Elizabeth Katkin: Explaining why fertility treatment access is so uneven in the U.S. "I think on the scientific side, progress in fertility, like many other illnesses, it's making leaps and bounds... but the financial side is a little bleaker." — Elizabeth Katkin: Summarizing her view that science is improving faster than affordability or policy.

Implications: Listeners are left with a clear view that fertility decline is both a demographic challenge and a healthcare-access problem. The future looks scientifically promising, but without broader insurance coverage and clearer laws, access will remain unequal and expensive.